Maynard Um
-
-
-
-
-
-
-
Prime Medicine, Inc. (PRME) Tops Q3 EPS by 11c
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Neutral Rating on Prime Medicine (PRME)
-
-
-
-
-
-
-
Prime Medicine (PRME) PT Lowered to $12 at Chardan Capital Markets
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Prime Medicine (PRME)
-
-
-
-
-
-
-
JMP Securities Starts Prime Medicine (PRME) at Market Outperform
-
-
-
-
-
-
-
Citi Reiterates Buy Rating on Prime Medicine (PRME)
-
-
-
-
-
404,886 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

